Seroconversion panels for hepatitis B and HIV
Three new seroconversion panels provide difficult- to-find patient samples for Hepatitis B and HIV and have been tested on today’s market-leading assays. Each panel represents a single donor and demonstrates how that donor’s blood converts in the presence of the disease during the sample collection period, presenting a unique challenge to the assay. Each product’s data sheet provides a graphical depiction of the donor’s seroconversion, along with comparative data that enables customers to review their test results against the results of other industry assays. HBV Seroconversion Panel (PHM938) comprises six undiluted plasma samples from a single donor drawn over a six-day period and is HBV DNA positive from the first bleed. HBV Seroconversion Panel (PHM939) provides five undiluted plasma samples from a single donor drawn over a 21-day period and is also HBV DNA positive from the first bleed. These panels allow for challenging members for HBsAg assays and HBeAg assays, delivering results for both rapid and qualitative HBsAg methods. HIV-1 Seroconversion Panel (PRB978) provides seven undiluted plasma samples from a single donor and is designed to challenge HIV RNA positive members on traditional antibody methods.
Supplier: SeraCare Life Sciences
Website:
